Global Tissue Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Tissue Diagnostics Market is presumed to reach the market size of nearly USD 12.26 Billion by 2032 from USD 6.02 Billion in 2023 with a CAGR of 8.22% under the study period 2024-2032.

Tissue Diagnostics is a technique which is one among the finest set in cancer diagnosis and monitoring and is the important driver in the market growth. Tissue based diagnosis technique enables to figure out the reason and impact of the disorder in a patient. Due to the unhealthy habits of people, the prevalence of cancer cases is rising over the years and so is propelling the growth of the market. Cancer diagnosis and treatment at initial stages will result in better possibilities of survival and the demand for diagnostics will register substantial growth by urging labs to improve efficiency in the diagnosis procedure to maximize health protection in sufferers. In developed countries there is adequate health consciousness than the developing countries for which different factors are credible as low health literacy, economic factors and enhancing regulatory necessities impede the market growth.

MARKET DYNAMICS

Tissue is a bunch or series of cells which execute a specific function and encompass essential biological information. Tissue specimens are used for cancer diagnosis and monitoring, where it apprehends the biological background of the disorder. The three main categories of tissue diagnosis are Immunohistochemistry, Hematoxylin and Eosin and In situ hybridization. Hematoxylin and Eosin tints work better with a mixture of fixatives and shows a wide range of cytoplasmic, extracellular matrix features and nuclear. Immunohistochemistry is known as the one among the vastly used new diagnostic traits where proteins are tinted utilizing antibodies and the last In-situ hybridization recognizes specific nucleotide series in the tissues.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Tissue Diagnostics. The growth and trends of Tissue Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Tissue Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Immunohistochemistry (Instruments (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other Products), Consumables (Antibodies, Reagents, Kits))
In Situ Hybridization (Instruments, Consumables, Software)
Primary & Special Staining
Digital Pathology and Workflow (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication)
Anatomic Pathology (Instruments (Microtomes & Cryostat Microtomes, Tissue Processors, Automatic Strainers, Other Products), Consumables (Reagents & Antibodies, Probes & Kits, Others)

By Application

Breast Cancer
Non-small Cell Lung Cancer
Prostate Cancer
Gastric Cancer
Other Cancers

By End-use

Hospitals
Research Laboratories
Pharmaceutical Organizations
Contract Research Organizations (CROs)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Tissue Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Tissue Diagnostics market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens, Danaher, BioMeRieux SA, Qiagen, BD, Merck KGaA, GE Healthcare, BioGenex, Cell Signaling Technology Inc., Bio SB, DiaGenic ASA, Agilent Technologies. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11211672

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. TISSUE DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

5.1. Overview By Technology
5.2. Historical and Forecast Data
5.3. Analysis By Technology
5.4. Immunohistochemistry (Instruments (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other Products), Consumables (Antibodies, Reagents, Kits)) Historic and Forecast Sales By Regions
5.5. In Situ Hybridization (Instruments, Consumables, Software) Historic and Forecast Sales By Regions
5.6. Primary & Special Staining Historic and Forecast Sales By Regions
5.7. Digital Pathology and Workflow (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication) Historic and Forecast Sales By Regions
5.8. Anatomic Pathology (Instruments (Microtomes & Cryostat Microtomes, Tissue Processors, Automatic Strainers, Other Products), Consumables (Reagents & Antibodies, Probes & Kits, Others) Historic and Forecast Sales By Regions

6. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Breast Cancer Historic and Forecast Sales By Regions
6.5. Non-small Cell Lung Cancer Historic and Forecast Sales By Regions
6.6. Prostate Cancer Historic and Forecast Sales By Regions
6.7. Gastric Cancer Historic and Forecast Sales By Regions
6.8. Other Cancers Historic and Forecast Sales By Regions

7. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data
7.3. Analysis By End-use
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Research Laboratories Historic and Forecast Sales By Regions
7.6. Pharmaceutical Organizations Historic and Forecast Sales By Regions
7.7. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions

8. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE TISSUE DIAGNOSTICS COMPANIES

9.1. Tissue Diagnostics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF TISSUE DIAGNOSTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. F. Hoffmann-La Roche Ltd.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Abbott Laboratories
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Thermo Fisher Scientific Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Siemens
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Danaher
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. BioMeRieux SA
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Qiagen
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. BD
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Merck KGaA
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. GE Healthcare
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. BioGenex
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Cell Signaling Technology Inc.
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Bio SB
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. DiaGenic ASA
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments
10.17. Agilent Technologies
- 10.17.1 Company Overview
- 10.17.2 Company Revenue
- 10.17.3 Products
- 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies